ANAPTYSBIO, INC 3
3 · First Tracks Biotherapeutics, Inc. · Filed Apr 1, 2026
Insider Transaction Report
Form 3
ANAPTYSBIO, INC
10% Owner
Holdings
- 100
Common Stock
[F1]
Footnotes (1)
- [F1]In connection with the spin-off of First Tracks Biotherapeutics, Inc. ("First Tracks") by the Reporting Person, as defined in the Separation and Distribution Agreement, dated April 1, 2026, between the Reporting Person and First Tracks, a wholly owned subsidiary of the Reporting Person, the Reporting Person on April 1, 2026 owns all 100 outstanding shares of common stock of First Tracks.
Signature
/s/ Dan Faga|2026-04-01